Verrica Pharmaceuticals Inc. Public Float
Verrica Pharmaceuticals Inc. (VRCA) had Public Float of $27.30 million as of 2025-06-30, per its 10-K filed 2026-03-11.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-11
- 2025-06-30: Entity Public Float $27.30M.
- 2024-06-28: Entity Public Float $190.10M.
- 2023-06-30: Entity Public Float $152.40M.
- 2022-06-30: Entity Public Float $31.50M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $27.30M 10-K · filed 2026-03-11 |
| 2024-06-28 | $190.10M 10-K · filed 2025-03-11 |
| 2023-06-30 | $152.40M 10-K · filed 2024-02-29 |
| 2022-06-30 | $31.50M 10-K · filed 2023-03-06 |
| 2021-06-30 | $185.60M 10-K · filed 2022-03-02 |
| 2020-06-30 | $173.20M 10-K · filed 2021-03-17 |
| 2019-06-28 | $181.40M 10-K · filed 2020-03-13 |
| 2018-06-29 | $244.60M 10-K · filed 2019-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |